Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Sarcoma 7Sarcoma, Ewing 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neurofibrosarcoma 2Nerve Sheath Neoplasms 2Lymphoma 2Liposarcoma 2Hodgkin Disease 2Histiocytoma, Angiomatoid Fibrous 2Granuloma, Plasma Cell 2Fibrosarcoma 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pleuropulmonary blastoma 1Perivascular Epithelioid Cell Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms, Adipose Tissue 1

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disorders of Sex Development × Ifosfamide × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡